SK48893A3 - Using of protrombine fragments - Google Patents

Using of protrombine fragments Download PDF

Info

Publication number
SK48893A3
SK48893A3 SK488-93A SK48893A SK48893A3 SK 48893 A3 SK48893 A3 SK 48893A3 SK 48893 A SK48893 A SK 48893A SK 48893 A3 SK48893 A3 SK 48893A3
Authority
SK
Slovakia
Prior art keywords
thrombin
activity
fragments
prothrombin fragments
meisotrombin
Prior art date
Application number
SK488-93A
Other languages
English (en)
Slovak (sk)
Inventor
Hartmut Lang
Berta Moritz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of SK48893A3 publication Critical patent/SK48893A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
SK488-93A 1992-05-15 1993-05-14 Using of protrombine fragments SK48893A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0100092A AT397391B (de) 1992-05-15 1992-05-15 Verwendung von prothrombinfragmenten

Publications (1)

Publication Number Publication Date
SK48893A3 true SK48893A3 (en) 1993-12-08

Family

ID=3504644

Family Applications (1)

Application Number Title Priority Date Filing Date
SK488-93A SK48893A3 (en) 1992-05-15 1993-05-14 Using of protrombine fragments

Country Status (14)

Country Link
US (1) US5529905A (fr)
EP (1) EP0570355B1 (fr)
JP (1) JPH0630793A (fr)
AT (2) AT397391B (fr)
CA (1) CA2096076A1 (fr)
CZ (1) CZ88093A3 (fr)
DE (1) DE59309254D1 (fr)
DK (1) DK0570355T3 (fr)
ES (1) ES2126641T3 (fr)
FI (1) FI107409B (fr)
HU (1) HU219457B (fr)
MX (1) MX9302830A (fr)
NO (1) NO308140B1 (fr)
SK (1) SK48893A3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430204A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Arzneimittel, welches als Gegenmittel für Blut-Antikoagulanzien geeignet ist und seine Verwendung
US6165795A (en) * 1998-06-25 2000-12-26 Cardiovascular Diagnostics, Inc. Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles
DE19904674A1 (de) 1999-02-04 2000-08-31 Haemosys Gmbh Verfahren zur Bestimmung der Konzentration von Thrombininhibitoren
US6413737B1 (en) * 1999-07-09 2002-07-02 Cohesion Technologies, Inc. Ecarin prothrombin protease and methods
US20050221414A1 (en) 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163764D1 (en) * 1980-10-09 1984-06-28 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin-bm
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
DE59109048D1 (de) * 1990-02-14 1998-10-15 Pentapharm Ag Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
CA2070813C (fr) * 1990-11-05 1996-10-29 Hendrik Coenraad Hemker Une methode permettant de determiner la concentration d'anticoagulants

Also Published As

Publication number Publication date
CA2096076A1 (fr) 1993-11-16
ATA100092A (de) 1993-08-15
DK0570355T3 (da) 1999-08-30
EP0570355A1 (fr) 1993-11-18
NO931772D0 (no) 1993-05-14
NO931772L (no) 1993-11-16
HUT64698A (en) 1994-02-28
CZ88093A3 (en) 1993-12-15
FI932194A (fi) 1993-11-16
HU9301316D0 (en) 1993-09-28
DE59309254D1 (de) 1999-02-11
AT397391B (de) 1994-03-25
US5529905A (en) 1996-06-25
ES2126641T3 (es) 1999-04-01
NO308140B1 (no) 2000-07-31
FI932194A0 (fi) 1993-05-14
MX9302830A (es) 1994-05-31
JPH0630793A (ja) 1994-02-08
EP0570355B1 (fr) 1998-12-30
HU219457B (hu) 2001-04-28
ATE175243T1 (de) 1999-01-15
FI107409B (fi) 2001-07-31

Similar Documents

Publication Publication Date Title
Koppelman et al. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII
Mertens et al. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX
Kumar et al. Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom
AU705596B2 (en) Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state
AU694931B2 (en) A method for detecting disturbances of the protein C/protein S system
Ofosu et al. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor
Mesters et al. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va
Jesty The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system
SK48893A3 (en) Using of protrombine fragments
Rabiet et al. Thrombin Metz: Characterization of the dysfunctional thrombin derived from a variant of human prothrombin
Weinstein et al. Species specificity of the fibrinolytic effects of activated protein C
Walker et al. The molecular mechanisms of heparin action: III. The anticoagulant properties of polyanetholesulfonate
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
Walker et al. The molecular mechanisms of heparin action: II. Separation of functionally different heparins by affinity chromatography
US5476771A (en) Test for quantitative thrombin time
CA2137342A1 (fr) Test quantitatif pour la determination du temps de thrombine
CA2065370C (fr) Facteur viii:ca dosage chromogene
HU216866B (hu) Eljárás és reagens fibrinogén meghatározására
Kandall et al. Determinants of Prothrombinase Activity and Modification of Prothrombin Conversion by Thrombin‐Treated Factor V
AU729843B2 (en) Method for the functional detection of disorders in the protein C system
Wagenvoord et al. Development of a sensitive and rapid chromogenic factor IX assay for clinical use
Muntean et al. Factor VIII influences binding of factor IX and factor X to intact human platelets
JP2677546B2 (ja) Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤
Busch Factors influencing human thrombin generation during fibrin glue manufacturing
Esmon The role of protein C and thrombomodulin in the regulation of blood coagulation